rewirebio.iobenchmarks
Configuration

Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)

Clair3 v1.0.8, tumour-only, PacBio HiFi: Germline caller run on the tumour BAM (ONT model r1041_e82_400bps_sup_v420); calls tagged by ClairS-TO's panels of normals removed, the rest treated as somatic.

2 evaluations · 14 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Evaluations and results

2 evaluations · 14 results. Different protocols are not a single leaderboard.

Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)

Sorted by AUPRC (indel only, tumour-only, 50x tumour coverage) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationProtocol and datasetAUPRC (indel only, tumour-only, 50x tumour coverage)AUPRC (SNV only, tumour-only, 50x tumour coverage)F1 (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)F1 (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)False negatives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)False negatives (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)False positives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)False positives (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)Precision (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)Precision (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)Recall (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)Recall (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)True positives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)True positives (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)EvaluationPacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)0.137Not reported0.2Not reported377Not reported1,482Not reported0.136Not reported0.382Not reported233Not reported
Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)EvaluationPacBio HiFi COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7a)Not reported0.558Not reported0.653Not reported5,855Not reported29,409Not reported0.53Not reported0.85Not reported33,231
All 14 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.137 AUPRC (indel only, tumour-only, 50x tumour coverage)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'Indel', column 'AUPRC'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.2 F1 (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'Indel', column 'F1-score'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
377 False negatives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'Indel', column 'FN'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
1,482 False positives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'Indel', column 'FP'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.136 Precision (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'Indel', column 'Precision'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.382 Recall (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'Indel', column 'Recall'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic indels (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
233 True positives (indel only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only Indel (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-indel

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'Indel', column 'TP'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.558 AUPRC (SNV only, tumour-only, 50x tumour coverage)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'SNV', column 'AUPRC'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.653 F1 (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'SNV', column 'F1-score'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
5,855 False negatives (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'SNV', column 'FN'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
29,409 False positives (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'SNV', column 'FP'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.53 Precision (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'SNV', column 'Precision'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
0.85 Recall (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'SNV', column 'Recall'
Configuration: Clair3 v1.0.8, tumour-only, PacBio HiFi (Chen et al. 2025)Protocol: PacBio HiFi COLO829 tumour-only, 50x, somatic SNVs (Chen et al. 2025 Supplementary Table 7a)
Dataset: COLO829 tumour PacBio HiFi Revio WGS (ClairS-TO benchmark)
33,231 True positives (SNV only, tumour-only, 50x tumour coverage, at the best-F1 threshold)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Clair3 on pacbio-colo829 tumour-only SNV (Chen et al. 2025)

somatic-clairs-to-20261011-protocol-pacbio-colo829-snv

Aggregation: Not reported

ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling; ClairS-TO Supplementary Information (Supplementary Tables 1-8 and command lines); ClairS-TO Source Data workbook · Supplementary Table 7a, Dataset 'COLO829', Caller 'Clair3', Tumor coverage '50x', Type 'SNV', column 'TP'

Source checking is not independent reproduction. Release 2026-10-22-1b7cf027e4f6.

Use this configuration

How it works, versions and access
Strengths, limitations and unresolved questions

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-22-1b7cf027e4f6
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-10-22-1b7cf027e4f6 · Record review: source checked

3 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: somatic-clairs-to-20261011-config-clair3-pacbio-hifi

areas
dna-genomes
contexts
clinical_research
method types
supervised_machine_learning
reported name
Clair3
version
v1.0.8
foundation model eligible
false
parameters
Germline caller run on the tumour BAM (ONT model r1041_e82_400bps_sup_v420); calls tagged by ClairS-TO's panels of normals removed, the rest treated as somatic
access reuse
Public open-source software and released models
source locator
Supplementary Information 'Command lines used'; Supplementary Tables 2 and 7 row labels
provenance note
Clair3 as run on PacBio HiFi tumour-only data in the cited comparison.
Related records

Suggest a correction